Cargando…
S108: A SYSTEMATIC POST-MARKETING (PM) REVIEW OF RARE INFUSION-RELATED REACTIONS (IRRS) PRESENTING AS PAIN EVENTS DURING OR AFTER CRIZANLIZUMAB INFUSION IN PATIENTS WITH SICKLE CELL DISEASE (SCD)
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811864/ http://dx.doi.org/10.1097/01.HS9.0000821400.77896.85 |
| _version_ | 1784644523303895040 |
|---|---|
| author | Kanter, J Shah, A Joshi, V Mehta, H Levine, M Arunagiri, U Paulose, J Donohue, B Scalera, A Manwani, D |
| author_facet | Kanter, J Shah, A Joshi, V Mehta, H Levine, M Arunagiri, U Paulose, J Donohue, B Scalera, A Manwani, D |
| author_sort | Kanter, J |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8811864 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88118642022-02-22 S108: A SYSTEMATIC POST-MARKETING (PM) REVIEW OF RARE INFUSION-RELATED REACTIONS (IRRS) PRESENTING AS PAIN EVENTS DURING OR AFTER CRIZANLIZUMAB INFUSION IN PATIENTS WITH SICKLE CELL DISEASE (SCD) Kanter, J Shah, A Joshi, V Mehta, H Levine, M Arunagiri, U Paulose, J Donohue, B Scalera, A Manwani, D Hemasphere Oral Presentations Lippincott Williams & Wilkins 2022-01-31 /pmc/articles/PMC8811864/ http://dx.doi.org/10.1097/01.HS9.0000821400.77896.85 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Presentations Kanter, J Shah, A Joshi, V Mehta, H Levine, M Arunagiri, U Paulose, J Donohue, B Scalera, A Manwani, D S108: A SYSTEMATIC POST-MARKETING (PM) REVIEW OF RARE INFUSION-RELATED REACTIONS (IRRS) PRESENTING AS PAIN EVENTS DURING OR AFTER CRIZANLIZUMAB INFUSION IN PATIENTS WITH SICKLE CELL DISEASE (SCD) |
| title | S108: A SYSTEMATIC POST-MARKETING (PM) REVIEW OF RARE INFUSION-RELATED REACTIONS (IRRS) PRESENTING AS PAIN EVENTS DURING OR AFTER CRIZANLIZUMAB INFUSION IN PATIENTS WITH SICKLE CELL DISEASE (SCD) |
| title_full | S108: A SYSTEMATIC POST-MARKETING (PM) REVIEW OF RARE INFUSION-RELATED REACTIONS (IRRS) PRESENTING AS PAIN EVENTS DURING OR AFTER CRIZANLIZUMAB INFUSION IN PATIENTS WITH SICKLE CELL DISEASE (SCD) |
| title_fullStr | S108: A SYSTEMATIC POST-MARKETING (PM) REVIEW OF RARE INFUSION-RELATED REACTIONS (IRRS) PRESENTING AS PAIN EVENTS DURING OR AFTER CRIZANLIZUMAB INFUSION IN PATIENTS WITH SICKLE CELL DISEASE (SCD) |
| title_full_unstemmed | S108: A SYSTEMATIC POST-MARKETING (PM) REVIEW OF RARE INFUSION-RELATED REACTIONS (IRRS) PRESENTING AS PAIN EVENTS DURING OR AFTER CRIZANLIZUMAB INFUSION IN PATIENTS WITH SICKLE CELL DISEASE (SCD) |
| title_short | S108: A SYSTEMATIC POST-MARKETING (PM) REVIEW OF RARE INFUSION-RELATED REACTIONS (IRRS) PRESENTING AS PAIN EVENTS DURING OR AFTER CRIZANLIZUMAB INFUSION IN PATIENTS WITH SICKLE CELL DISEASE (SCD) |
| title_sort | s108: a systematic post-marketing (pm) review of rare infusion-related reactions (irrs) presenting as pain events during or after crizanlizumab infusion in patients with sickle cell disease (scd) |
| topic | Oral Presentations |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811864/ http://dx.doi.org/10.1097/01.HS9.0000821400.77896.85 |
| work_keys_str_mv | AT kanterj s108asystematicpostmarketingpmreviewofrareinfusionrelatedreactionsirrspresentingaspaineventsduringoraftercrizanlizumabinfusioninpatientswithsicklecelldiseasescd AT shaha s108asystematicpostmarketingpmreviewofrareinfusionrelatedreactionsirrspresentingaspaineventsduringoraftercrizanlizumabinfusioninpatientswithsicklecelldiseasescd AT joshiv s108asystematicpostmarketingpmreviewofrareinfusionrelatedreactionsirrspresentingaspaineventsduringoraftercrizanlizumabinfusioninpatientswithsicklecelldiseasescd AT mehtah s108asystematicpostmarketingpmreviewofrareinfusionrelatedreactionsirrspresentingaspaineventsduringoraftercrizanlizumabinfusioninpatientswithsicklecelldiseasescd AT levinem s108asystematicpostmarketingpmreviewofrareinfusionrelatedreactionsirrspresentingaspaineventsduringoraftercrizanlizumabinfusioninpatientswithsicklecelldiseasescd AT arunagiriu s108asystematicpostmarketingpmreviewofrareinfusionrelatedreactionsirrspresentingaspaineventsduringoraftercrizanlizumabinfusioninpatientswithsicklecelldiseasescd AT paulosej s108asystematicpostmarketingpmreviewofrareinfusionrelatedreactionsirrspresentingaspaineventsduringoraftercrizanlizumabinfusioninpatientswithsicklecelldiseasescd AT donohueb s108asystematicpostmarketingpmreviewofrareinfusionrelatedreactionsirrspresentingaspaineventsduringoraftercrizanlizumabinfusioninpatientswithsicklecelldiseasescd AT scaleraa s108asystematicpostmarketingpmreviewofrareinfusionrelatedreactionsirrspresentingaspaineventsduringoraftercrizanlizumabinfusioninpatientswithsicklecelldiseasescd AT manwanid s108asystematicpostmarketingpmreviewofrareinfusionrelatedreactionsirrspresentingaspaineventsduringoraftercrizanlizumabinfusioninpatientswithsicklecelldiseasescd |